The biggest buzz at the Healthcare Convention & Exhibitors Association annual meeting in Toronto was, not surprisingly, the potential impact of the new voluntary ethical code issued by the Pharmaceutical Research and Manufacturers of America (PhRMA), which went into effect on July 1, just a week or so after the June 22 to 25 meeting. To address those concerns, Timothy Casady, deputy general counsel, Eli Lilly and Co., gave a special presentation on PhRMA's Code on Interactions with ...

Register for Complete Access (Valid Email Required)

By registering on MeetingsNet now, you'll not only gain access to THE BUZZ AT HCEA: NEW PHARMA CODE, you'll get exclusive access to a large archive of premium content.

Already registered? here.